ASCENDIS PHARMA

ascendis-pharma-logo

Ascendis Pharma has built a high value pipeline with the aim of changing clinical treatment paradigms. Using our innovative TransCon prodrug technology platform, we continue to identify new opportunities addressing areas of high unmet medical need. TransCon is applicable to all drug classes, and is currently being used to create superior prodrugs of proteins, peptides and small molecules. Depending on choice of TransCon Carrier, either systemic or localized drug exposure is achieved, while dosin... g frequency is determined by the choice of TransCon Linker. The prodrugs are new chemical entities with new patent life. Product development process is de-risked, as the prodrugs release the active component in its native and unmodified form, maintaining the original drug’s well known mode of action.

#SimilarOrganizations #People #Financial #Website #More

ASCENDIS PHARMA

Social Links:

Industry:
Biotechnology Clinical Trials Health Care

Founded:
2006-01-01

Address:
Palo Alto, California, United States

Country:
United States

Website Url:
http://www.ascendispharma.com

Total Employee:
251+

Status:
Active

Contact:
650 352 8389

Email Addresses:
[email protected]

Total Funding:
585.73 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Google Universal Analytics Domain Not Resolving


Similar Organizations

affimed-logo

Affimed

Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals

Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

carebox-healthcare-logo

Carebox Healthcare

Carebox connects patients and physicians exploring treatment options with clinical trials.

cofactor-genomics-logo

Cofactor Genomics

Cofactor Genomics builds multidimensional models of disease to deliver true precision medicine.

intarcia-therapeutics-logo

Intarcia Therapeutics

Intarcia Therapeutics develops therapies for diseases that require long-term chronic treatment.

novabay-pharmaceuticals-logo

NovaBay Pharmaceuticals

NovaBay Pharmaceuticals is a biopharmaceutical company developing products for the eye care market.

recro-pharma-logo

Recro Pharma

Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.

x4-pharmaceuticals-logo

X4 Pharmaceuticals

X4 Pharmaceuticals a clinical-stage oncology company developing best-in-class oral small molecule CXCR4 antagonists for the treatment.

Current Employees Featured

not_available_image

Harald Rau
Harald Rau Senior Vice President, Chief Scientific Officer @ Ascendis Pharma
Senior Vice President, Chief Scientific Officer

birgitte-volck_image

Birgitte Volck
Birgitte Volck Non Executive Director @ Ascendis Pharma
Non Executive Director
2016-05-01

michael-wolff-jensen_image

Michael Wolff Jensen
Michael Wolff Jensen Chairman Of The Board Of Directors @ Ascendis Pharma
Chairman Of The Board Of Directors
2008-01-01

jan-møller-mikkelsen_image

Jan Møller Mikkelsen
Jan Møller Mikkelsen Co-Founder, President and CEO @ Ascendis Pharma
Co-Founder, President and CEO

not_available_image

Michael Beckert
Michael Beckert Chief Medical Officer (acting) @ Ascendis Pharma
Chief Medical Officer (acting)

lotte-sønderbjerg_image

Lotte Sønderbjerg
Lotte Sønderbjerg SVP Chief Administrative Offer Managing Director Ascendis GmbH @ Ascendis Pharma
SVP Chief Administrative Offer Managing Director Ascendis GmbH
2007-12-01

Founder


jan-møller-mikkelsen_image

Jan Møller Mikkelsen

Stock Details


Company's stock symbol is NASDAQ:ASND

Acquisitions List

Date Company Article Price
2007-12-13 Complex Biosystems Complex Biosystems acquired by Ascendis Pharma N/A

Investors List

sofinnova-ventures_image

Sofinnova Investments

Sofinnova Investments investment in Post-IPO Equity - Ascendis Pharma

venrock_image

Venrock

Venrock investment in Series D - Ascendis Pharma

sofinnova-ventures_image

Sofinnova Investments

Sofinnova Investments investment in Series D - Ascendis Pharma

rock-springs-capital_image

Rock Springs Capital

Rock Springs Capital investment in Series D - Ascendis Pharma

ra-capital-management_image

RA Capital Management

RA Capital Management investment in Series D - Ascendis Pharma

orbimed-advisors_image

OrbiMed

OrbiMed investment in Series D - Ascendis Pharma

vivo-capital_image

Vivo Capital

Vivo Capital investment in Series D - Ascendis Pharma

gilde-healthcare-partners_image

Gilde Healthcare

Gilde Healthcare investment in Series A - Ascendis Pharma

technostart_image

TechnoStart

TechnoStart investment in Series A - Ascendis Pharma

sofinnova-partners_image

Sofinnova Partners

Sofinnova Partners investment in Series A - Ascendis Pharma

Investments List

Date Company Article Money raised
2021-01-08 Visen Pharmaceuticals Ascendis Pharma investment in Series B - Visen Pharmaceuticals 150 M USD
2018-11-13 Visen Pharmaceuticals Ascendis Pharma investment in Series A - Visen Pharmaceuticals 40 M USD

Official Site Inspections

http://www.ascendispharma.com Semrush global rank: 2.31 M Semrush visits lastest month: 8.09 K

  • Host name: 141.193.213.20
  • IP address: 141.193.213.20
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Ascendis Pharma" on Search Engine